244 related articles for article (PubMed ID: 18843777)
1. Androgen deficiency and defective intracrine processing of dehydroepiandrosterone in salivary glands in Sjögren's syndrome.
Porola P; Virkki L; Przybyla BD; Laine M; Patterson TA; Pihakari A; Konttinen YT
J Rheumatol; 2008 Nov; 35(11):2229-35. PubMed ID: 18843777
[TBL] [Abstract][Full Text] [Related]
2. Low salivary dehydroepiandrosterone and androgen-regulated cysteine-rich secretory protein 3 levels in Sjögren's syndrome.
Laine M; Porola P; Udby L; Kjeldsen L; Cowland JB; Borregaard N; Hietanen J; Ståhle M; Pihakari A; Konttinen YT
Arthritis Rheum; 2007 Aug; 56(8):2575-84. PubMed ID: 17665393
[TBL] [Abstract][Full Text] [Related]
3. Failure of oral DHEA treatment to increase local salivary androgen outputs of female patients with Sjögren's syndrome.
Porola P; Straub RH; Virkki LM; Konttinen YT; Nordström DC
Scand J Rheumatol; 2011; 40(5):387-90. PubMed ID: 21877998
[TBL] [Abstract][Full Text] [Related]
4. Healthy human salivary glands contain a DHEA-sulphate processing intracrine machinery, which is deranged in primary Sjögren's syndrome.
Spaan M; Porola P; Laine M; Rozman B; Azuma M; Konttinen YT
J Cell Mol Med; 2009 Jul; 13(7):1261-70. PubMed ID: 19298523
[TBL] [Abstract][Full Text] [Related]
5. Sjögren's syndome and extragonadal sex steroid formation: a clue to a better disease control?
Konttinen YT; Stegajev V; Al-Samadi A; Porola P; Hietanen J; Ainola M
J Steroid Biochem Mol Biol; 2015 Jan; 145():237-44. PubMed ID: 25158020
[TBL] [Abstract][Full Text] [Related]
6. Androgens and integrins in salivary glands in Sjogren's syndrome.
Porola P; Laine M; Virtanen I; Pöllänen R; Przybyla BD; Konttinen YT
J Rheumatol; 2010 Jun; 37(6):1181-7. PubMed ID: 20436081
[TBL] [Abstract][Full Text] [Related]
7. Endocrine alterations in primary Sjogren's syndrome: an overview.
Mavragani CP; Fragoulis GE; Moutsopoulos HM
J Autoimmun; 2012 Dec; 39(4):354-8. PubMed ID: 22695186
[TBL] [Abstract][Full Text] [Related]
8. Laminin isoform profiles in salivary glands in Sjögren's syndrome.
Porola P; Mackiewicz Z; Laine M; Baretto G; Stegaev V; Takakubo Y; Takagi M; Ainola M; Konttinen YT
Adv Clin Chem; 2011; 55():35-59. PubMed ID: 22126023
[TBL] [Abstract][Full Text] [Related]
9. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
Labrie F; Bélanger A; Cusan L; Candas B
J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
[TBL] [Abstract][Full Text] [Related]
10. The influence of sex steroids on Sjögren's syndrome.
Porola P; Laine M; Virkki L; Poduval P; Konttinen YT
Ann N Y Acad Sci; 2007 Jun; 1108():426-32. PubMed ID: 17894007
[TBL] [Abstract][Full Text] [Related]
11. Are women with Sjögren's syndrome androgen-deficient?
Sullivan DA; Bélanger A; Cermak JM; Bérubé R; Papas AS; Sullivan RM; Yamagami H; Dana MR; Labrie F
J Rheumatol; 2003 Nov; 30(11):2413-9. PubMed ID: 14677186
[TBL] [Abstract][Full Text] [Related]
12. Sex steroids in Sjögren's syndrome.
Konttinen YT; Fuellen G; Bing Y; Porola P; Stegaev V; Trokovic N; Falk SS; Liu Y; Szodoray P; Takakubo Y
J Autoimmun; 2012 Aug; 39(1-2):49-56. PubMed ID: 22300712
[TBL] [Abstract][Full Text] [Related]
13. Low serum levels of sex steroids are associated with disease characteristics in primary Sjogren's syndrome; supplementation with dehydroepiandrosterone restores the concentrations.
Forsblad-d'Elia H; Carlsten H; Labrie F; Konttinen YT; Ohlsson C
J Clin Endocrinol Metab; 2009 Jun; 94(6):2044-51. PubMed ID: 19318446
[TBL] [Abstract][Full Text] [Related]
14. Exosomal secretion of death bullets: a new way of apoptotic escape?
Trokovic N; Pöllänen R; Porola P; Stegaev V; Hetzel U; Tivesten Å; Engdahl C; Carlsten H; Forsblad-d'Elia H; Fagman JB; Lagerquist M; Konttinen YT
Am J Physiol Endocrinol Metab; 2012 Oct; 303(8):E1015-24. PubMed ID: 22912365
[TBL] [Abstract][Full Text] [Related]
15. Synaptotagmin-1 overexpression under inflammatory conditions affects secretion in salivary glands from Sjögren's syndrome patients.
Cortés J; Hidalgo J; Aguilera S; Castro I; Brito M; Urra H; Pérez P; Barrera MJ; Carvajal P; Urzúa U; González S; Molina C; Bahamondes V; Hermoso M; González MJ
J Autoimmun; 2019 Feb; 97():88-99. PubMed ID: 30391023
[TBL] [Abstract][Full Text] [Related]
16. Dehydroepiandrosterone (DHEA) substitution treatment for severe fatigue in DHEA-deficient patients with primary Sjögren's syndrome.
Virkki LM; Porola P; Forsblad-d'Elia H; Valtysdottir S; Solovieva SA; Konttinen YT
Arthritis Care Res (Hoboken); 2010 Jan; 62(1):118-24. PubMed ID: 20191499
[TBL] [Abstract][Full Text] [Related]
17. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging.
Labrie F; Bélanger A; Cusan L; Gomez JL; Candas B
J Clin Endocrinol Metab; 1997 Aug; 82(8):2396-402. PubMed ID: 9253307
[TBL] [Abstract][Full Text] [Related]
18. Sex steroid hormones in primary Sjögren's syndrome.
Brennan MT; Sankar V; Leakan RA; Grisius MM; Collins MT; Fox PC; Baum BJ; Pillemer SR
J Rheumatol; 2003 Jun; 30(6):1267-71. PubMed ID: 12784401
[TBL] [Abstract][Full Text] [Related]
19. Immunohistopathology of Sjögren's syndrome.
Konttinen YT; Porola P; Konttinen L; Laine M; Poduval P
Autoimmun Rev; 2006 Nov; 6(1):16-20. PubMed ID: 17110311
[TBL] [Abstract][Full Text] [Related]
20. Presence of hepatitis C virus RNA in the salivary glands of patients with Sjögren's syndrome and hepatitis C virus infection.
Toussirot E; Le Huédé G; Mougin C; Balblanc JC; Bettinger D; Wendling D
J Rheumatol; 2002 Nov; 29(11):2382-5. PubMed ID: 12415596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
